Wealthtrust Axiom LLC’s Pfizer Inc Position
Does Wealthtrust Axiom LLC own Pfizer Inc (PFE)? Yes — 258.1K shares worth $7M (+1.78% of its 13F portfolio) as of Q1 2026, up from 240.2K shares the prior filed quarter.
Position Value
$7M
Q1 2026
Shares
258.1K
% of Portfolio
+1.78%
Quarters Held
30
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 258.1K | $7M | +1.78% |
| Q4 2025 | 240.2K | $6M | +1.54% |
| Q3 2025 | 241.6K | $6M | +1.65% |
| Q2 2025 | 239.9K | $6M | +1.71% |
| Q1 2025 | 238.1K | $6M | +1.84% |
| Q4 2024 | 197.6K | $5M | +1.56% |
| Q3 2024 | 178.6K | $5M | +1.53% |
| Q2 2024 | 162.1K | $5M | +1.50% |
| Q1 2024 | 148.3K | $4M | +1.33% |
| Q4 2023 | 121.6K | $4M | +1.17% |
| Q3 2023 | 101.5K | $3M | +1.21% |
| Q2 2023 | 115.4K | $4M | +1.40% |
| Q1 2023 | 115.4K | $5M | +1.60% |
| Q4 2022 | 114.8K | $6M | +2.05% |
| Q3 2022 | 116.8K | $5M | +1.95% |
| Q2 2022 | 116.9K | $6M | +2.18% |
| Q1 2022 | 117.0K | $6M | +1.89% |
| Q4 2021 | 117.5K | $7M | +2.22% |
| Q3 2021 | 118.4K | $5M | +1.72% |
| Q2 2021 | 121.3K | $5M | +1.52% |
| Q1 2021 | 118.9K | $4M | +1.46% |
| Q4 2020 | 88.3K | $3M | +1.18% |
| Q3 2020 | 88.6K | $3M | +1.40% |
| Q2 2020 | 88.1K | $3M | +1.27% |
| Q1 2020 | 91.1K | $3M | +1.46% |
| Q4 2019 | 95.5K | $4M | +1.25% |
| Q3 2019 | 98.6K | $4M | +1.25% |
| Q2 2019 | 100.1K | $4M | +1.51% |
| Q1 2019 | 100.6K | $4M | +1.52% |
| Q4 2018 | 101.5K | $4M | +1.81% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wealthtrust Axiom LLC’s full portfolio or all institutional holders of PFE.